Innovacyn, Inc., parent company of the Vetericyn and Puracyn brands, provides premier healthcare products. The company currently markets advanced healthcare products based on the MicrocynŽ Technology platform to both the human and animal markets.
The Vetericyn and Puracyn family of products is based upon the shelf-stable Microcyn¨ Technology platform, which helps to prevent and treat infections in chronic and acute wounds. Microcyn Technology has demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores. Unlike other products it does not harm healthy tissue and thus speeds healing.
Innovacyn's wound and infection products are proudly made in the USA.